Baeken Marius W, Schwarz Mario, Kern Andreas, Moosmann Bernd, Hajieva Parvana, Behl Christian
Institute for Pathobiochemistry, The Autophagy Lab, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology Graduate University, Onna, Okinawa, 904 0495, Japan.
Cell Death Discov. 2021 Oct 12;7(1):286. doi: 10.1038/s41420-021-00683-x.
The sirtuin (SIRT) protein family has been of major research interest over the last decades because of their involvement in aging, cancer, and cell death. SIRTs have been implicated in gene and metabolic regulation through their capacity to remove acyl groups from lysine residues in proteins in an NAD-dependent manner, which may alter individual protein properties as well as the histone-DNA interaction. Since SIRTs regulate a wide range of different signaling cascades, a fine-tuned homeostasis of these proteins is imperative to guarantee the function and survival of the cell. So far, however, how exactly this homeostasis is established has remained unknown. Here, we provide evidence that neuronal SIRT degradation in Parkinson's disease (PD) models is executed by autophagy rather than the proteasome. In neuronal Lund human mesencephalic (LUHMES) cells, all seven SIRTs were substrates for autophagy and showed an accelerated autophagy-dependent degradation upon 1-methyl-4-phenylpyridinium (MPP) mediated oxidative insults in vitro, whereas the proteasome did not contribute to the removal of oxidized SIRTs. Through blockade of endogenous HO generation and supplementation with the selective radical scavenger phenothiazine (PHT), we could identify HO-derived species as the responsible SIRT-oxidizing agents. Analysis of all human SIRTs suggested a conserved regulatory motif based on cysteine oxidation, which may have triggered their degradation via autophagy. High amounts of HO, however, rapidly carbonylated selectively SIRT2, SIRT6, and SIRT7, which were found to accumulate carbonylation-prone amino acids. Our data may help in finding new strategies to maintain and modify SIRT bioavailability in neurodegenerative disorders.
在过去几十年中,沉默调节蛋白(SIRT)家族一直是主要的研究热点,因为它们与衰老、癌症和细胞死亡有关。SIRTs通过以NAD依赖的方式从蛋白质中的赖氨酸残基上去除酰基,参与基因和代谢调节,这可能会改变单个蛋白质的特性以及组蛋白与DNA的相互作用。由于SIRTs调节广泛的不同信号级联反应,这些蛋白质的精确稳态对于保证细胞的功能和存活至关重要。然而,到目前为止,这种稳态究竟是如何建立的仍然未知。在这里,我们提供证据表明,帕金森病(PD)模型中神经元SIRT的降解是由自噬而非蛋白酶体执行的。在神经元性隆德人脑中脑(LUHMES)细胞中,所有七种SIRTs都是自噬的底物,并且在体外1-甲基-4-苯基吡啶鎓(MPP)介导的氧化损伤后显示出自噬依赖性降解加速,而蛋白酶体对氧化的SIRTs的清除没有作用。通过阻断内源性HO的产生并补充选择性自由基清除剂吩噻嗪(PHT),我们可以确定HO衍生的物质是负责氧化SIRT的试剂。对所有人类SIRTs的分析表明存在基于半胱氨酸氧化的保守调节基序,这可能触发了它们通过自噬的降解。然而,大量的HO会迅速选择性地使SIRT2、SIRT6和SIRT7发生羰基化,这些蛋白被发现积累了易于发生羰基化的氨基酸。我们的数据可能有助于找到在神经退行性疾病中维持和调节SIRT生物利用度的新策略。